Teladoc Health: Cathie Wood Favorite Still Struggling

Summary:

  • Teladoc’s Q4 report showed slowing revenue growth and missed street estimates, but losses were better than the prior year period.
  • The company’s revenue guidance for the current quarter, full year, and next two years was fairly downbeat.
  • TDOC’s losses are improving, and its balance sheet is in fair shape, leading to a depressed valuation and the potential for activist investor involvement or an acquisition.

Conceptual image of transparent coloured cubes

Richard Drury/DigitalVision via Getty Images

After the bell on Tuesday, we received fourth quarter results from Teladoc (NYSE:TDOC). The tele-health provider is one of the Cathie Wood favorites and prior pandemic darlings, seeing its shares soar to over $300 a


Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Investors are always reminded that before making any investment, you should do your own proper due diligence on any name directly or indirectly mentioned in this article. Investors should also consider seeking advice from a broker or financial adviser before making any investment decisions. Any material in this article should be considered general information, and not relied on as a formal investment recommendation.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.


Leave a Reply

Your email address will not be published. Required fields are marked *